TY - JOUR
T1 - Smoking cessation in pregnant women
AU - Klesges, L. M.
AU - Johnson, K. C.
AU - Ward, K. D.
AU - Barnard, M.
N1 - Funding Information:
This work is supported by grants HD37225 and DA10527 from the National Institutes of Health, the Partnership for Women's and Children's Health, a joint foundation of Methodist Hospital, LeBonheur Hospital, and the University of Tennessee Health Science Center, and by LHS Inc., a local charitable foundation supporting children's health promotion.
PY - 2001
Y1 - 2001
N2 - Cigarette smoking is considered the most significant modifiable cause of adverse pregnancy outcomes in US women. Smoking cessation in pregnant patients is one of the most effective ways to reduce negative pregnancy outcomes of fetal growth retardation, preterm delivery, and perinatal mortality. Research evidence documenting the effectiveness of health care provider interventions in smoking cessation has led to the PHS recommendation to screen and counsel every patient.16 Materials from the PHS and NCI are available to assist health care providers in developing a brief office-based intervention. Patient materials for distribution are also available.16, 57 Increased use of office-based cessation strategies, of cessation programs in community-based interventions, and of pharmacologic therapies is necessary to remedy the public health burden of fetal exposure to tobacco. Relapse prevention methods using office-based and social support systems are important to improve long-term maintenance of cessation in women who quit smoking during pregnancy.
AB - Cigarette smoking is considered the most significant modifiable cause of adverse pregnancy outcomes in US women. Smoking cessation in pregnant patients is one of the most effective ways to reduce negative pregnancy outcomes of fetal growth retardation, preterm delivery, and perinatal mortality. Research evidence documenting the effectiveness of health care provider interventions in smoking cessation has led to the PHS recommendation to screen and counsel every patient.16 Materials from the PHS and NCI are available to assist health care providers in developing a brief office-based intervention. Patient materials for distribution are also available.16, 57 Increased use of office-based cessation strategies, of cessation programs in community-based interventions, and of pharmacologic therapies is necessary to remedy the public health burden of fetal exposure to tobacco. Relapse prevention methods using office-based and social support systems are important to improve long-term maintenance of cessation in women who quit smoking during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=0034974811&partnerID=8YFLogxK
M3 - Review article
C2 - 11430176
AN - SCOPUS:0034974811
SN - 0889-8545
VL - 28
SP - 269
EP - 282
JO - Obstetrics and Gynecology Clinics of North America
JF - Obstetrics and Gynecology Clinics of North America
IS - 2
ER -